Our results from an analysis using a variant in HMGCR (rs12916‐T) to proxy statin intervention suggest that statins may hold potential in prostate cancer prevention, but our inference is tentative and requires further investigation in larger sample sizes. The gene discussed is HMGCR; the disease is prostate carcinoma.